Alaunos Therapeutics, Inc. Logo

Alaunos Therapeutics, Inc.

Clinical-stage immuno-oncology company developing TCR-T cell therapies for solid tumors.

TCRT | US

Overview

Corporate Details

ISIN(s):
US98973P1012
LEI:
Country:
United States of America
Address:
501 E LAS OLAS BLVD, 33301 FORT LAUDERDALE

Description

Alaunos Therapeutics, Inc. is a clinical-stage cellular immuno-oncology company developing T-cell receptor (TCR)-T cell therapies for the treatment of solid tumors. The company's approach targets cancer-specific neoantigens that arise from genomic hotspot mutations. It utilizes its proprietary hunTR® (human neoantigen T cell Receptor) platform as a discovery engine to identify and expand its library of tumor-specific TCRs. For manufacturing its cell therapies, Alaunos employs the *Sleeping Beauty* non-viral gene transfer system, a technology noted for its favorable safety profile and rapid, cost-effective production. The company's mission is to deliver tumor-specific T-cell therapies to cancer patient populations with unmet clinical needs.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-12-23 18:18
8-K
English ZIP 65.3 KB
2025-12-11 23:17
424B8
English ZIP 153.5 KB
2025-12-05 21:20 English ZIP 417.8 KB
2025-11-27 03:32
4
English ZIP 7.2 KB
2025-11-27 03:26
4
English ZIP 7.1 KB
2025-11-27 03:26
4
English ZIP 6.7 KB
2025-11-14 22:15
10-Q
English ZIP 1.0 MB
2025-11-07 22:34
S-3/A
English ZIP 206.1 KB
2025-10-31 19:13 English ZIP 4.0 MB
2025-10-30 23:48 English ZIP 3.1 MB
2025-10-22 01:25
S-1
English ZIP 237.8 KB
2025-10-16 22:58 English ZIP 8.1 KB
2025-10-02 02:10
S-3/A
English ZIP 196.2 KB
2025-09-09 02:11
S-3/A
English ZIP 306.9 KB
2025-09-05 23:20 English ZIP 10.4 KB

Automate Your Workflow. Get a real-time feed of all Alaunos Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Alaunos Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Alaunos Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Alteogen Inc. Logo
Biopharmaceutical firm developing biologics with proprietary drug delivery technologies.
South Korea
196170
AlzeCure Pharma Logo
Develops therapies for severe diseases, focusing on Alzheimer's and pain.
Sweden
ALZCUR
ANAPTYSBIO, INC Logo
Clinical-stage biotech developing immunology therapeutics for inflammatory diseases.
United States of America
ANAB
AngioLab, Inc. Logo
Develops angiogenesis inhibitors for pharmaceuticals and health functional foods.
South Korea
251280
Anixa Biosciences Inc Logo
A clinical-stage biotech developing therapies and vaccines to treat and prevent cancer.
United States of America
ANIX
Annovis Bio, Inc. Logo
A clinical-stage drug platform company developing therapies for neurodegenerative diseases.
United States of America
ANVS
Develops and manufactures DNA-based technologies for genetic medicine and diagnostics.
United States of America
APDN
Aprea Therapeutics, Inc. Logo
Clinical-stage biopharma developing cancer therapeutics via synthetic lethality.
United States of America
APRE
AprilBio Co.,Ltd. Logo
Develops long-acting biologic drugs for autoimmune diseases, oncology, and rare diseases.
South Korea
397030
Aptahem AB Logo
A clinical-stage biotech developing aptamer-based drugs for life-threatening conditions.
Sweden
APTA

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.